Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
J Health Popul Nutr ; 2007 Dec; 25(4): 465-8
Article in English | IMSEAR | ID: sea-719

ABSTRACT

The role of specific immunoglobulins at mucosal sites in imparting protection against disease, such as rotavirus-associated diarrhoea, is well-established. Oral immunoglobulin therapy with egg yolk-derived anti-rotavirus immunoglobulins has previously been shown to achieve moderate therapeutic effect in diarrhoea due to rotavirus in a clinical trial. Here, data on the therapeutic potential of the same immunoglobulin preparation in an infant mouse model of rotavirus-induced diarrhoea is presented. The use of an animal model has allowed therapy to be evaluated with higher doses of immunoglobulins and has suggested that an improved therapeutic effect can be achieved by increasing the dose in the clinical setting.


Subject(s)
Animals , Animals, Suckling , Antibodies, Viral/biosynthesis , Antigens, Viral/immunology , Diarrhea/immunology , Disease Models, Animal , Egg Yolk/immunology , Humans , Immunization, Passive , Immunoglobulins/immunology , Mice , Mice, Inbred BALB C , Random Allocation , Rotavirus/immunology , Rotavirus Infections/immunology
SELECTION OF CITATIONS
SEARCH DETAIL